CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	3 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Cash flows from operating activities:
Net loss	$ (2,926,270)	$ (7,828,644)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	218,346	109,726
Stock based compensation expense	396,991	1,998,524
Change in fair value of warrant liability		2,994,540
Loss on conversion of promissory notes		980,842
Common stock issued for consulting services	58,120
Bad debt expense	10,000	2,779
Change in operating assets and liabilities:
Accounts receivable	(4,480)	(282,502)
Prepaid expenses and other current assets and deposits	71,896	(18,102)
Accounts payable and accrued liabilities	(320,825)	(253,997)
Deferred revenue	(224,524)	(59,001)
Net cash used in operating activities	(2,720,746)	(2,355,835)
Cash flows used in investing activities:
Purchase of property plant and equipment	(51,795)	(30,825)
Purchase of intangible assets	(14,301)
Net cash used in investing activities	(66,096)	(30,825)
Cash flows from financing activities:
Net proceeds from sale of common stock and warrants	7,853,155	7,956,050
Proceeds from the exercise of warrants	4,410
Purchase and cancelation of previously issued warrants		(4,090,952)
Net cash provided by financing activities	7,857,565	3,865,098
Net increase in cash and cash equivalents	5,070,723	1,478,438
Cash and cash equivalents at beginning of period	7,312,184	1,393,132
Cash and cash equivalents at end of period	$ 12,382,907	$ 2,871,570
Supplemental Disclosures of Cash Flow Information:
Cash paid during period for interest
Cash paid during period for taxes
Non-cash investing and financing activities:
Common stock issued for cashless exercise of options and warrants	$ 49
Property, plant and equipment acquired, and included in accounts payable	40,908	$ 181,104
Intangible assets acquired, and included in accounts payable	17,841
Issuance of options to settle accrued liability	$ 42,335